Business
AstraZeneca US COVID-19 vaccine trial may resume as soon as this week – Sydney Morning Herald
The pharma giant’s coronavirus vaccine trial in the United States is expected to resume as early as this week after the US Food and Drug Administration completed…
In a research and development briefing held for CSL investors on Tuesday, the company’s chief scientific officer Dr Andrew Nash said preparations to produce both vaccines were moving along well and production of the AstraZeneca product could start early next year.
He said the AstraZeneca/Oxford and University of Queensland projects used different approaches, with UQ’s being a more “classical” vaccine model while AstraZeneca’s was a newer approach, and it was a positive that both projects could be…
-
Noosa News22 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News15 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General15 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News24 hours agoCampers evacuated as fire crews battle blaze